Patents by Inventor Robert Mass
Robert Mass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7613521Abstract: The present invention relates to a wireless handheld device that is configured to communicate with an implanted device using inductive telemetry. The handheld device is preferably battery operated and includes a battery powered controller and a battery powered inductive coil. The inductive coil is configured to communicate with an inductive coil of the implanted device using inductive telemetry. The handheld device may include one battery voltage source that powers both the controller and the inductive coil, or multiple battery voltage sources to power the controller and inductive coil separately. In a single battery voltage source embodiment, the voltage may be amplified or reduced to meet the power needs of the controller and inductive coil. In a multiple battery voltage source embodiment, the voltage sources may be combined to increase the power output requirements of the inductive coil.Type: GrantFiled: January 16, 2004Date of Patent: November 3, 2009Assignee: Cardiac Pacemakers, Inc.Inventors: William Robert Mass, Jay William Axelrod, Jason Allen Malone, Richard Earl Stein, Robert Joseph Gaskill
-
Publication number: 20070258984Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: June 14, 2007Publication date: November 8, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070166753Abstract: The invention provides a method for more effective treatment of patients susceptible to or diagnosed with tumors overexpressing HER2, as determined by a gene amplification assay, with a HER2 antibody. Such method comprises administering a cancer-treating dose of the HER2 antibody, preferably in addition to chemotherapeutic agents, to a subject in whose tumor cells her2 has been found to be amplified e.g., by fluorescent in situ hybridization.Type: ApplicationFiled: March 23, 2007Publication date: July 19, 2007Inventor: ROBERT MASS
-
Publication number: 20070160608Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: July 12, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Homgren, Robert Mass, William Novotny
-
Publication number: 20070154483Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: July 5, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070148178Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: June 28, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070148177Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: June 28, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070071749Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: March 29, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070071748Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: March 29, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070071718Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: March 29, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070036790Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: February 15, 2007Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070036754Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: February 15, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070036753Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: February 15, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070031413Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: February 8, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20070025999Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: September 29, 2006Publication date: February 1, 2007Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny
-
Publication number: 20060228745Abstract: The invention provides a method for more effective treatment of patients susceptible to or diagnosed with tumors overexpressing ErbB, as determined by a gene amplification assay, with an ErbB antagonist. Such method comprises administering a cancer-treating dose of the ErbB antagonist, preferably in addition to chemotherapeutic agents, to a subject in whose tumor cells ErbB has been found to be amplified e.g., by fluorescent in situ hybridization. ErbB antagonists described include an anti-HER2 antibody. Pharmaceutical packaging for providing the components for such treatment is also provided.Type: ApplicationFiled: May 26, 2006Publication date: October 12, 2006Inventor: Robert Mass
-
Publication number: 20050186208Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.Type: ApplicationFiled: May 28, 2004Publication date: August 25, 2005Applicant: Genentech, Inc.Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert Mass, William Novotny